ACTINOBAC BIOMED, INC.
KENDALL PARK, NJ · CIK 0001712650 · Biotech · Private
Leukothera (LtxA), a recombinant protein therapeutic derived from bacterial leukotoxin that binds LFA-1 on malignant B-cells to induce cell death
- Grants
- $1.0M
- 2 awards
- Sector median: 1
- Raised
- $3.4M
- 2 Form D · Jun 2018
- 100 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 6
- 5 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2015201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Targeting B-cell lymphoma with Leukothera-phase II | $894,222 | |
| Federal grant | Department of Health and Human Services · Phase II · Targeting B-cell lymphoma with Leukothera-phase II | $140,000 | |
| Private capital raised | Form D · SEC | $2,400,000 | |
| Private capital raised | Form D · SEC | $1,000,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3359 | Neomorph | — | — |
| 3360 | ALPHAMEMORY, LLC | — | — |
| 3361 | CORMEDIX, INC. | — | $3.5M |
| 3362 | ACTINOBAC BIOMED, INC. | — | $3.4M |
| 3363 | Vernal Biosciences, Inc. | — | $22M |
| 3364 | AVICANNA INC. | — | $10M |
| 3365 | Adipo Therapeutics, LLC | — | $6.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Peter AlffDirector
- PETER ALFFDirector
- BENJAMIN BELINKADirector · Executive Officer
- Benjamin Belinka, Jr.Director · Executive Officer
- James GolubieskiDirector
- JAMES GOLUBIESKIDirector
- Scott KachlanyDirector
- SCOTT KACHLANYDirector
Patents
- Method of Treating Autoimmune Inflammatory Crohn's Diseasegranted
- Treatment And Diagnosis Of Inflammatory Disorders And Hivgranted
- Treatment And Diagnosis Of Inflammatory Disorders And Hivgranted
- Treatment And Diagnosis Of Inflammatory Disorders And Hivgranted
- Treatment And Diagnosis Of Inflammatory Disorders And Hivgranted
- Treatment And Diagnosis Of Ocular Diseaseapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.